Department of Molecular and Biomedical Pharmacology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Endocrinology. 2013 Aug;154(8):2807-20. doi: 10.1210/en.2013-1139. Epub 2013 Jun 4.
Although glucocorticoids (GCs) are known to exert numerous effects in the hippocampus, their chronic regulatory functions remain poorly understood. Moreover, evidence is inconsistent regarding the long-standing hypothesis that chronic GC exposure promotes brain aging/Alzheimer disease. Here, we adrenalectomized male F344 rats at 15 months of age, maintained them for 3 months with implanted corticosterone (CORT) pellets producing low or intermediate (glucocorticoid receptor-activating) blood levels of CORT, and performed microarray/pathway analyses in hippocampal CA1. We defined the chronic GC-dependent transcriptome as 393 genes that exhibited differential expression between intermediate and low CORT groups. Short-term CORT (4 days) did not recapitulate this transcriptome. Functional processes/pathways overrepresented by chronic CORT-up-regulated genes included learning/plasticity, differentiation, glucose metabolism, and cholesterol biosynthesis, whereas processes overrepresented by CORT-down-regulated genes included inflammatory/immune/glial responses and extracellular structure. These profiles indicate that GCs chronically activate neuronal/metabolic processes while coordinately repressing a glial axis of reactivity/inflammation. We then compared the GC transcriptome with a previously defined hippocampal aging transcriptome, revealing a high proportion of common genes. Although CORT and aging moved expression of some common genes in the same direction, the majority were shifted in opposite directions by CORT and aging (eg, glial inflammatory genes down-regulated by CORT are up-regulated with aging). These results contradict the hypothesis that GCs simply promote brain aging and also suggest that the opposite direction shifts during aging reflect resistance to CORT regulation. Therefore, we propose a new model in which aging-related GC resistance develops in some target pathways, whereas GC overstimulation develops in others, together generating much of the brain aging phenotype.
虽然糖皮质激素(GCs)在海马体中具有多种作用已为人所知,但它们的慢性调节功能仍知之甚少。此外,长期以来认为慢性 GC 暴露会促进大脑衰老/阿尔茨海默病的假说证据并不一致。在这里,我们在 15 个月大时对雄性 F344 大鼠进行肾上腺切除术,用植入的皮质酮(CORT)丸维持 3 个月,使 CORT 血液水平保持在低或中等(糖皮质激素受体激活)水平,并在海马 CA1 进行了微阵列/途径分析。我们将慢性 GC 依赖性转录组定义为 393 个基因,这些基因在中间和低 CORT 组之间表现出差异表达。短期 CORT(4 天)不能重现这种转录组。慢性 CORT 上调基因所代表的功能过程/途径包括学习/可塑性、分化、葡萄糖代谢和胆固醇生物合成,而 CORT 下调基因所代表的过程包括炎症/免疫/神经胶质反应和细胞外结构。这些图谱表明,GCs 慢性激活神经元/代谢过程,同时协调抑制胶质反应/炎症轴。然后,我们将 GC 转录组与之前定义的海马体衰老转录组进行比较,发现有很大比例的共同基因。尽管 CORT 和衰老使一些共同基因的表达朝着相同的方向移动,但大多数基因在 CORT 和衰老的作用下朝着相反的方向移动(例如,CORT 下调的胶质炎症基因在衰老时上调)。这些结果与 GC 简单促进大脑衰老的假设相矛盾,也表明衰老过程中相反方向的转变反映了对 CORT 调节的抵抗。因此,我们提出了一个新的模型,即与衰老相关的 GC 抵抗在某些靶途径中发展,而 GC 过度刺激在其他途径中发展,共同产生了大部分大脑衰老表型。